{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:34:43Z","timestamp":1788435283457,"version":"build-2803163510"},"reference-count":147,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ajog.2020.07.026","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T21:23:45Z","timestamp":1595021025000},"page":"S1196-S1210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"S","title":["Toward personalized management of chronic hypertension in pregnancy"],"prefix":"10.1016","volume":"226","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1355-610X","authenticated-orcid":false,"given":"Laura A.","family":"Magee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikos","family":"Kametas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"von Dadelszen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2020.07.026_bib1","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/j.jacc.2020.03.028","article-title":"Incidence and long-term outcomes of hypertensive disorders of pregnancy","volume":"75","author":"Garovic","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ajog.2020.07.026_bib2","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1161\/HYPERTENSIONAHA.119.12968","article-title":"Changes in the prevalence of chronic hypertension in pregnancy, United States, 1970 to 2010","volume":"74","author":"Ananth","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.07.026_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002783","article-title":"The incidence of pregnancy hypertension in India, Pakistan, Mozambique, and Nigeria: a prospective population-level analysis","volume":"16","author":"Magee","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.ajog.2020.07.026_bib4","doi-asserted-by":"crossref","unstructured":"Scott G, Gillon TE, Pels A, von Dadelszen P, Magee LA. Guidelines\u2014similarities and dissimilarities: a systematic review of international clinical practice guidelines for pregnancy hypertension. Am J Obstet Gynecol 2022;226:1222-36.","DOI":"10.1016\/j.ajog.2020.08.018"},{"key":"10.1016\/j.ajog.2020.07.026_bib5","first-page":"e13","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.07.026_bib6","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/AOG.0000000000002870","article-title":"Maternal outcomes associated with lower range stage 1 hypertension","volume":"132","author":"Sutton","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1161\/HYPERTENSIONAHA.118.11196","article-title":"Aspirin effect on adverse pregnancy outcomes associated with stage 1 hypertension in a high-risk cohort","volume":"72","author":"Hauspurg","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.07.026_bib8","doi-asserted-by":"crossref","first-page":"g2301","DOI":"10.1136\/bmj.g2301","article-title":"Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis","volume":"348","author":"Bramham","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2020.07.026_bib9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1471-0528.2010.02754.x","article-title":"Optimal timing of delivery in pregnancies with pre-existing hypertension","volume":"118","author":"Hutcheon","year":"2011","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2020.07.026_bib10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/uog.17493","article-title":"Chronic hypertension and adverse pregnancy outcome: a cohort study","volume":"50","author":"Panaitescu","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib11","doi-asserted-by":"crossref","first-page":"i1753","DOI":"10.1136\/bmj.i1753","article-title":"High Risk of Pre-eclampsia Identification Group. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies","volume":"353","author":"Bartsch","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2020.07.026_bib12","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/10641955.2017.1311340","article-title":"Incidence of superimposed preeclampsia among pregnant Asian women with chronic hypertension","volume":"36","author":"Boriboonhirunsarn","year":"2017","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2020.07.026_bib13","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1161\/HYPERTENSIONAHA.107.107565","article-title":"Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study","volume":"51","author":"Chappell","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.07.026_bib14","first-page":"403","article-title":"Pregnancy outcomes in women with preeclampsia superimposed on chronic hypertension with and without severe features","volume":"34","author":"Moussa","year":"2017","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2020.07.026_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.preghy.2017.01.001","article-title":"Incidence and pregnancy outcomes of superimposed preeclampsia with or without proteinuria among women with chronic hypertension","volume":"7","author":"Nakanishi","year":"2017","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2020.07.026_bib16","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/0002-9378(94)90276-3","article-title":"The prognosis of pregnancy in women with chronic hypertension","volume":"171","author":"Rey","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib17","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1056\/NEJM199809033391004","article-title":"Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units","volume":"339","author":"Sibai","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.07.026_bib18","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1471-0528.2007.01315.x","article-title":"The Control of Hypertension In Pregnancy Study pilot trial","volume":"114","author":"Magee","year":"2007","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2020.07.026_bib19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1471-0528.1996.tb09662.x","article-title":"Perinatal morbidity in chronic hypertension","volume":"103","author":"McCowan","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"issue":"Suppl A","key":"10.1016\/j.ajog.2020.07.026_bib20","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.genm.2008.03.007","article-title":"Differential effects of sex steroids in young and aged female mRen2.Lewis rats: a model of estrogen and salt-sensitive hypertension","volume":"5","author":"Chappell","year":"2008","journal-title":"Gend Med"},{"key":"10.1016\/j.ajog.2020.07.026_bib21","doi-asserted-by":"crossref","first-page":"134.e1","DOI":"10.1016\/j.ajog.2011.10.878","article-title":"Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions","volume":"206","author":"Bateman","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib22","author":"Ehret"},{"key":"10.1016\/j.ajog.2020.07.026_bib23","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.jogc.2018.07.001","article-title":"No. 367-2019 Canadian guideline for physical activity throughout pregnancy","volume":"40","author":"Mottola","year":"2018","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.ajog.2020.07.026_bib24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism: a cross-sectional study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajog.2020.07.026_bib25","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1097\/AOG.0000000000003020","article-title":"ACOG Practice Bulletin no. 203: chronic hypertension in pregnancy","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib26","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1007\/s00246-015-1182-9","article-title":"Maternal hypertension during pregnancy and the risk of congenital heart defects in offspring: a systematic review and meta-analysis","volume":"36","author":"Ramakrishnan","year":"2015","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.ajog.2020.07.026_bib27","doi-asserted-by":"crossref","first-page":"337.e1","DOI":"10.1016\/j.ajog.2014.09.031","article-title":"Chronic hypertension in pregnancy and the risk of congenital malformations: a cohort study","volume":"212","author":"Bateman","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib28","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/1471-0528.13138","article-title":"Maternal hypertensive disorders, antihypertensive medication use, and the risk of birth defects: a case-control study","volume":"122","author":"van Gelder","year":"2015","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2020.07.026_bib29","first-page":"387","article-title":"Estimating the birth prevalence and pregnancy outcomes of congenital malformations worldwide","volume":"9","author":"Moorthie","year":"2018","journal-title":"J\u00a0Community Genet"},{"key":"10.1016\/j.ajog.2020.07.026_bib30","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/aje\/kws393","article-title":"Risk of miscarriage among black women and white women in a U.S. prospective cohort study","volume":"177","author":"Mukherjee","year":"2013","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2020.07.026_bib31","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa055202","article-title":"Major congenital malformations after first-trimester exposure to ACE inhibitors","volume":"354","author":"Cooper","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.07.026_bib32","doi-asserted-by":"crossref","first-page":"658310","DOI":"10.1155\/2012\/658310","article-title":"The fetal safety of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers","volume":"2012","author":"Moretti","year":"2012","journal-title":"Obstet Gynecol Int"},{"key":"10.1016\/j.ajog.2020.07.026_bib33","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3109\/01443615.2011.579197","article-title":"Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers","volume":"31","author":"Walfisch","year":"2011","journal-title":"J\u00a0Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1161\/HYPERTENSIONAHA.118.11946","article-title":"Rationale for ambulatory and home blood pressure monitoring thresholds in the 2017 American College of Cardiology\/American Heart Association Guideline","volume":"73","author":"Muntner","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.07.026_bib37","unstructured":"Self-monitoring of blood pressure in pregnancy. Information for healthcare professionals. London: Royal College of Obstetricians & Gynaecologists; 2020. Available at: https:\/\/www.rcog.org.uk\/globalassets\/documents\/guidelines\/2020-03-30-self-monitoring-of-blood-pressure-in-pregnancy.pdf. Accessed May 20, 2020."},{"key":"10.1016\/j.ajog.2020.07.026_bib38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/10641950109152639","article-title":"Evaluation of ambulatory and self-initiated blood pressure monitors by pregnant and postpartum women","volume":"20","author":"Taylor","year":"2001","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2020.07.026_bib39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.preghy.2019.09.018","article-title":"A\u00a0randomised controlled trial of blood pressure self-monitoring in the management of hypertensive pregnancy. OPTIMUM-BP: a feasibility trial","volume":"18","author":"Pealing","year":"2019","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2020.07.026_bib40","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.preghy.2019.12.001","article-title":"Home blood pressure monitoring in the antenatal and postpartum period: a systematic review meta-analysis","volume":"19","author":"Kalafat","year":"2020","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2020.07.026_bib41","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/uog.19041","article-title":"Home blood-pressure monitoring in a hypertensive pregnant population: cost-minimization study","volume":"53","author":"Xydopoulos","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib42","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(10)60964-6","article-title":"Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial","volume":"376","author":"McManus","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2020.07.026_bib43","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/jama.2014.10057","article-title":"Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trial","volume":"312","author":"McManus","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2020.07.026_bib44","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/HYPERTENSIONAHA.118.10911","article-title":"Self-management of postnatal hypertension: the SNAP-HT trial","volume":"72","author":"Cairns","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.07.026_bib45","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1471-0528.2004.00516.x","article-title":"The natural history of white coat hypertension during pregnancy","volume":"112","author":"Brown","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2020.07.026_bib46","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.preghy.2018.08.452","article-title":"Diagnosis of white coat hypertension and pregnancy outcomes","volume":"14","author":"Rodrigues","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2020.07.026_bib47","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/HYPERTENSIONAHA.119.14627","article-title":"Maternal and perinatal outcomes of white coat hypertension during pregnancy: a systematic review and meta-analysis","volume":"76","author":"Johnson","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.07.026_bib48","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/HYPERTENSIONAHA.118.10917","article-title":"How do home and clinic blood pressure readings compare in pregnancy?","volume":"72","author":"Tucker","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.07.026_bib49","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/uog.19094","article-title":"Is home blood-pressure monitoring in hypertensive disorders of pregnancy consistent with clinic recordings?","volume":"52","author":"Kalafat","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib50","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.preghy.2017.01.002","article-title":"Reliability of home blood pressure monitoring devices in pregnancy","volume":"8","author":"Tremonti","year":"2017","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2020.07.026_bib54","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12911-019-0954-1","article-title":"Mobile phone apps for clinical decision support in pregnancy: a scoping review","volume":"19","author":"Carter","year":"2019","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/j.ajog.2020.07.026_bib55","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.preghy.2019.12.002","article-title":"Are blood pressure level and variability related to pregnancy outcome? Analysis of control of hypertension in pregnancy study data","volume":"19","author":"Magee","year":"2020","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2020.07.026_bib56","first-page":"725","article-title":"Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension","volume":"93","author":"Easterling","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib57","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/uog.20231","article-title":"Methods and considerations concerning cardiac output measurement in pregnant women: recommendations of the International Working Group on Maternal Hemodynamics","volume":"54","author":"Bijl","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib58","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/uog.18959","article-title":"Genetic and non-genetic risk factors for pre-eclampsia: umbrella review of systematic reviews and meta-analyses of observational studies","volume":"51","author":"Giannakou","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib59","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/uog.20117","article-title":"Prediction of pre-eclampsia: review of reviews","volume":"54","author":"Townsend","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib60","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/uog.17455","article-title":"Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11\u201313 weeks\u2019 gestation: comparison with NICE guidelines and ACOG recommendations","volume":"49","author":"O\u2019Gorman","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib61","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/uog.19039","article-title":"Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE","volume":"51","author":"Tan","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib62","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/aogs.12877","article-title":"Can adverse maternal and perinatal outcomes be predicted when blood pressure becomes elevated? Secondary analyses from the CHIPS (Control of Hypertension In Pregnancy Study) randomized controlled trial","volume":"95","author":"Magee","year":"2016","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2020.07.026_bib63","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/1471-0528.14029","article-title":"The performance of risk prediction models for pre-eclampsia using routinely collected maternal characteristics and comparison with models that include specialised tests and with clinical guideline decision rules: a systematic review","volume":"123","author":"Al-Rubaie","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2020.07.026_bib64","doi-asserted-by":"crossref","first-page":"650.e1","DOI":"10.1016\/j.ajog.2019.09.041","article-title":"Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population","volume":"221","author":"Chaemsaithong","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib65","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000477934","article-title":"First-trimester combined multimarker prospective study for the detection of pregnancies at a high risk of developing preeclampsia using the Fetal Medicine Foundation-algorithm","volume":"43","author":"Guizani","year":"2018","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajog.2020.07.026_bib66","doi-asserted-by":"crossref","first-page":"w14498","DOI":"10.4414\/smw.2017.14498","article-title":"First trimester combined screening for preeclampsia and small for gestational age - a single centre experience and validation of the FMF screening algorithm","volume":"147","author":"Mosimann","year":"2017","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.ajog.2020.07.026_bib67","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/ajo.12126","article-title":"Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancy","volume":"53","author":"Park","year":"2013","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib68","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1111\/1471-0528.13194","article-title":"Risk assessment for preeclampsia in nulliparous women at 11-13 weeks gestational age: prospective evaluation of two algorithms","volume":"122","author":"Skr\u00e5stad","year":"2015","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2020.07.026_bib69","doi-asserted-by":"crossref","first-page":"126.e1","DOI":"10.1016\/j.ajog.2017.10.024","article-title":"First-trimester screening for early and late preeclampsia using maternal characteristics, biomarkers, and estimated placental volume","volume":"218","author":"Sonek","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib71","article-title":"Preeclampsia screening and prediction","author":"Poon","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib72","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/uog.19019","article-title":"ASPRE trial: incidence of preterm pre-eclampsia in patients fulfilling ACOG and NICE criteria according to risk by FMF algorithm","volume":"51","author":"Poon","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib73","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/uog.19076","article-title":"Cost-effectiveness of first-trimester screening with early preventative use of aspirin in women at high risk of early-onset pre-eclampsia","volume":"53","author":"Ortved","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib74","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1161\/HYPERTENSIONAHA.118.11718","article-title":"Preeclampsia prevention using routine versus\u00a0screening test-indicated aspirin in low-risk women","volume":"72","author":"Mone","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.07.026_bib75","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/AOG.0000000000003413","article-title":"Strategies for prescribing aspirin to prevent preeclampsia: a cost-effectiveness analysis","volume":"134","author":"Mallampati","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib76","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.07.026_bib77","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2020.07.026_bib78","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM199803123381101","article-title":"Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units","volume":"338","author":"Caritis","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.07.026_bib79","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1471-0528.1993.tb14304.x","article-title":"Low dose aspirin in hypertensive pregnant women: effect on pregnancy outcome and prostacyclin-thromboxane balance in mother and newborn","volume":"100","author":"Viinikka","year":"1993","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib80","article-title":"Prevention with aspirin","author":"Poon","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib81","first-page":"CD001059","article-title":"Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems","volume":"10","author":"Hofmeyr","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2020.07.026_bib82","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/1471-0528.12613","article-title":"Calcium and Pre-eclampsia (CAP) Study Group. Low-dose calcium supplementation for preventing pre-eclampsia: a systematic review and commentary","volume":"121","author":"Hofmeyr","year":"2014","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2020.07.026_bib83","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0140-6736(18)31818-X","article-title":"Prepregnancy and early pregnancy calcium supplementation among women at high risk of pre-eclampsia: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"393","author":"Hofmeyr","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2020.07.026_bib84","author":"Hoy"},{"key":"10.1016\/j.ajog.2020.07.026_bib85","article-title":"New interventions for the prevention and treatment of preeclampsia","author":"Tong","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib86","article-title":"Prevention with heparin","author":"Llurba","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib87","article-title":"The role of statins for the prevention of preeclampsia","author":"Costantine","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib88","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S1701-2163(16)30592-8","article-title":"Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: an updated metaregression analysis","volume":"24","author":"von Dadelszen","year":"2002","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.ajog.2020.07.026_bib89","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(98)08049-0","article-title":"Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis","volume":"355","author":"von Dadelszen","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2020.07.026_bib90","first-page":"CD002252","article-title":"Antihypertensive drug therapy for mild to moderate hypertension during pregnancy","volume":"10","author":"Abalos","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2020.07.026_bib91","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1161\/HYPERTENSIONAHA.116.07862","article-title":"The CHIPS randomized controlled trial (Control of Hypertension In Pregnancy Study): is severe hypertension just an elevated blood pressure?","volume":"68","author":"Magee","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.07.026_bib92","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1404595","article-title":"Less-tight versus tight control of hypertension in pregnancy","volume":"372","author":"Magee","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.07.026_bib93","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","article-title":"Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice","volume":"72","author":"Brown","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.07.026_bib94","first-page":"526","article-title":"Hypertension Canada\u2019s 2018 guidelines for the management of hypertension in pregnancy","volume":"34","author":"Butalia","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ajog.2020.07.026_bib95","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.preghy.2019.08.166","article-title":"Management of non-severe pregnancy hypertension - a summary of the CHIPS trial (Control of Hypertension In Pregnancy Study) research publications","volume":"18","author":"Magee","year":"2019","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2020.07.026_bib96","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/HYPERTENSIONAHA.117.10689","article-title":"Influence of gestational age at initiation of antihypertensive therapy: secondary analysis of CHIPS trial data (Control of Hypertension In Pregnancy Study)","volume":"71","author":"Pels","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.07.026_bib97","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejogrb.2016.07.509","article-title":"Women\u2019s views and postpartum follow-up in the CHIPS trial (Control of Hypertension In Pregnancy Study)","volume":"206","author":"Vidler","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2020.07.026_bib98","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1161\/HYPERTENSIONAHA.116.07466","article-title":"The cost implications of less tight versus tight control of hypertension in pregnancy (CHIPS trial)","volume":"68","author":"Ahmed","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.07.026_bib99","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ajog.2015.04.013","article-title":"SMFM statement: benefit of antihypertensive therapy for mild-to-moderate chronic hypertension during pregnancy remains uncertain","volume":"213","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib100","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-0731","article-title":"Late pregnancy \u03b2 blocker exposure and risks of neonatal hypoglycemia and bradycardia","volume":"138","author":"Bateman","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2020.07.026_bib101","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1111\/bcp.13649","article-title":"Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials","volume":"84","author":"Sridharan","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ajog.2020.07.026_bib102","first-page":"CD004451","article-title":"Diuretics for preventing pre-eclampsia","volume":"1","author":"Churchill","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2020.07.026_bib103","doi-asserted-by":"crossref","first-page":"e005526","DOI":"10.1161\/JAHA.117.005526","article-title":"Impact of antihypertensive treatment on maternal and perinatal outcomes in pregnancy complicated by chronic hypertension: a systematic review and meta-analysis","volume":"6","author":"Webster","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.ajog.2020.07.026_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2020.03.016","article-title":"Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis","author":"Bellos","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0378-3782(77)90030-5","article-title":"Hypertension during pregnancy, with and without specific hypotensive treatment. II. The growth and development of the infant in the first year of life","volume":"1","author":"Mutch","year":"1977","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.ajog.2020.07.026_bib106","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0378-3782(77)90029-9","article-title":"Hypertension during pregnancy, with and without specific hypotensive treatment. I. Perinatal factors and neonatal morbidity","volume":"1","author":"Mutch","year":"1977","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.ajog.2020.07.026_bib107","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3389\/fphar.2017.00865","article-title":"Vitamin D enhances efficacy of oral nifedipine in treating preeclampsia with severe features: a double blinded, placebo-controlled and randomized clinical trial","volume":"8","author":"Shi","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ajog.2020.07.026_bib108","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/1471-0528.13569","article-title":"Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial","volume":"123","author":"Magee","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2020.07.026_bib109","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1081\/PRG-120028291","article-title":"Do commonly used oral antihypertensives alter fetal or neonatal heart rate characteristics? A systematic review","volume":"23","author":"Waterman","year":"2004","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2020.07.026_bib110","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1097\/HJH.0000000000001456","article-title":"In-utero exposure to antihypertensive medication and neonatal and child health outcomes: a systematic review","volume":"35","author":"Fitton","year":"2017","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ajog.2020.07.026_bib111","doi-asserted-by":"crossref","first-page":"l5119","DOI":"10.1136\/bmj.l5119","article-title":"Diagnosis and management of hypertension in pregnancy: summary of updated NICE guidance","volume":"366","author":"Webster","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2020.07.026_bib112","doi-asserted-by":"crossref","unstructured":"Magee LA, Khalil A, von Dadelszen P. Pregnancy hypertension diagnosis and care in COVID-19 era and beyond. Ultrasound Obstet Gynecol 2020 [Epub ahead of print].","DOI":"10.1002\/uog.22115"},{"key":"10.1016\/j.ajog.2020.07.026_bib113","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0140-6736(19)31282-6","article-title":"Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial","volume":"394","author":"Easterling","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2020.07.026_bib114","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.preghy.2019.09.019","article-title":"First-line antihypertensive treatment for severe hypertension in pregnancy: a systematic review and network meta-analysis","volume":"18","author":"Alavifard","year":"2019","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2020.07.026_bib115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.preghy.2014.01.003","article-title":"Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy","volume":"4","author":"Magee","year":"2014","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2020.07.026_bib116","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0140-6736(05)72599-X","article-title":"Fetal growth restriction","volume":"355","author":"Churchill","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2020.07.026_bib117","first-page":"427","article-title":"Treatment of hypertension in pregnancy: effect of atenolol on maternal disease, preterm delivery, and fetal growth","volume":"98","author":"Easterling","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib118","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0002-9149(97)00163-X","article-title":"Effect of atenolol on birth weight","volume":"79","author":"Lip","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ajog.2020.07.026_bib119","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0895-7061(99)00031-X","article-title":"Atenolol and fetal growth in pregnancies complicated by hypertension","volume":"12","author":"Lydakis","year":"1999","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ajog.2020.07.026_bib120","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.preghy.2018.09.010","article-title":"Maternal and perinatal outcomes associated with the use of renin-angiotensin system (RAS) blockers for chronic hypertension in early pregnancy","volume":"14","author":"Ahmed","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2020.07.026_bib121","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/AOG.0000000000001775","article-title":"Angiotensin-converting enzyme inhibitors and the risk of congenital malformations","volume":"129","author":"Bateman","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib122","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1161\/HYPERTENSIONAHA.112.196352","article-title":"Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review","volume":"60","author":"Bullo","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.07.026_bib123","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1161\/HYPERTENSIONAHA.116.08773","article-title":"Maternal antihypertensive medication use and congenital heart defects: updated results from the National Birth Defects Prevention Study","volume":"69","author":"Fisher","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.07.026_bib124","doi-asserted-by":"crossref","first-page":"d5931","DOI":"10.1136\/bmj.d5931","article-title":"Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study","volume":"343","author":"Li","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2020.07.026_bib125","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/bmj.332.7545.833","article-title":"Hypertension and ethnic group","volume":"332","author":"Brown","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2020.07.026_bib126","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/ajh.2010.105","article-title":"Ethnic differences in blood pressure response to first and second-line antihypertensive therapies in patients randomized in the ASCOT Trial","volume":"23","author":"Gupta","year":"2010","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ajog.2020.07.026_bib127","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1161\/01.HYP.0000209642.11448.e0","article-title":"Value of noninvasive hemodynamics to achieve blood pressure control in hypertensive subjects","volume":"47","author":"Smith","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.07.026_bib129","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/jhh.2016.50","article-title":"A\u00a0prediction model for the response to oral labetalol for the treatment of antenatal hypertension","volume":"31","author":"Stott","year":"2017","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.ajog.2020.07.026_bib130","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/uog.17335","article-title":"Longitudinal hemodynamics in acute phase of treatment with labetalol in hypertensive pregnant women to predict need for vasodilatory therapy","volume":"49","author":"Stott","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib131","first-page":"775","article-title":"Patient preferences and decisional needs when choosing a treatment approach for pregnancy hypertension: a stated preference study","volume":"36","author":"Metcalfe","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ajog.2020.07.026_bib134","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.preghy.2018.05.004","article-title":"The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice","volume":"13","author":"Brown","year":"2018","journal-title":"Pregnancy Hypertens"},{"issue":"3 Suppl 3","key":"10.1016\/j.ajog.2020.07.026_bib135","first-page":"49","article-title":"7th Brazilian guideline of arterial hypertension: chapter 9 - arterial hypertension in pregnancy","volume":"107","author":"Malachias","year":"2016","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.ajog.2020.07.026_bib136","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.lpm.2016.05.012","article-title":"Expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology","volume":"45","author":"Mounier-Vehier","year":"2016","journal-title":"Presse Med"},{"key":"10.1016\/j.ajog.2020.07.026_bib137","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/HYPERTENSIONAHA.119.12760","article-title":"Short-term prediction of adverse outcomes using the sFlt-1 (soluble fms-like tyrosine kinase 1)\/PlGF (placental growth factor) ratio in Asian women with suspected preeclampsia","volume":"74","author":"Bian","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.07.026_bib138","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1161\/CIRCULATIONAHA.113.003215","article-title":"Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study","volume":"128","author":"Chappell","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2020.07.026_bib140","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.07.026_bib141","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/uog.19178","article-title":"Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting","volume":"53","author":"Zeisler","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib142","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/HYPERTENSIONAHA.111.181735","article-title":"Angiogenic factors in superimposed preeclampsia: a longitudinal study of women with chronic hypertension during pregnancy","volume":"59","author":"Perni","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.07.026_bib143","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.kint.2015.10.012","article-title":"Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease","volume":"89","author":"Bramham","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajog.2020.07.026_bib144","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.preghy.2020.04.004","article-title":"Angiogenic factor abnormalities and risk of peripartum complications and prematurity among urban predominantly obese parturients with chronic hypertension","volume":"20","author":"Heimberger","year":"2020","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2020.07.026_bib145","doi-asserted-by":"crossref","first-page":"163.e1","DOI":"10.1016\/j.ajog.2011.09.019","article-title":"Can placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction?","volume":"206","author":"Benton","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.placenta.2016.03.010","article-title":"Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction","volume":"42","author":"Benton","year":"2016","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2020.07.026_bib147","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/uog.14860","article-title":"Diagnostic accuracy of placental growth factor and ultrasound parameters to predict the small-for-gestational-age infant in women presenting with reduced symphysis-fundus height","volume":"46","author":"Griffin","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib148","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1161\/HYPERTENSIONAHA.116.08547","article-title":"Diagnostic performance of placental growth\u00a0factor in women with suspected preeclampsia attending antenatal facilities in Maputo, Mozambique","volume":"69","author":"Ukah","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.07.026_bib149","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.preghy.2017.12.005","article-title":"Early diagnosis of preeclampsia using placental growth factor: an operational pilot study in Maputo, Mozambique","volume":"11","author":"Manriquez Rocha","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2020.07.026_bib150","doi-asserted-by":"crossref","first-page":"e1001589","DOI":"10.1371\/journal.pmed.1001589","article-title":"A\u00a0risk prediction model for the assessment and triage of women with hypertensive disorders of pregnancy in low-resourced settings: the miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) multi-country prospective cohort study","volume":"11","author":"Payne","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.ajog.2020.07.026_bib152","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(10)61351-7","article-title":"Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model","volume":"377","author":"von Dadelszen","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2020.07.026_bib154","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/HYPERTENSIONAHA.113.02293","article-title":"Angiogenic factors in diagnosis, management, and research in preeclampsia","volume":"63","author":"Rana","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.07.026_bib155","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1161\/HYPERTENSIONAHA.119.13997","article-title":"Angiogenic marker prognostic models in pregnant women with hypertension","volume":"75","author":"Perry","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.07.026_bib156","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/AOG.0000000000002800","article-title":"Timing of delivery in women with chronic hypertension","volume":"132","author":"Ram","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.026_bib157","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijgo.2014.04.010","article-title":"Pregnancy outcomes of expectant management of stable mild to moderate chronic hypertension as compared with planned delivery","volume":"127","author":"Hamed","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2020.07.026_bib158","first-page":"CD009273","article-title":"Planned early delivery versus expectant management for hypertensive disorders from 34 weeks gestation to term","volume":"1","author":"Cluver","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2020.07.026_bib160","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/10641955.2016.1239735","article-title":"Furosemide in postpartum management of severe preeclampsia: a randomized controlled trial","volume":"36","author":"Veena","year":"2017","journal-title":"Hypertens Pregnancy"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937820307456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937820307456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:35:01Z","timestamp":1757590501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937820307456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":147,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0002937820307456"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2020.07.026","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toward personalized management of chronic hypertension in pregnancy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2020.07.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}